Status:

RECRUITING

Combined Injury-site & Lumbosacral Epidural Spinal Cord Stimulation

Lead Sponsor:

The University of Hong Kong

Conditions:

Spinal Cord Injuries (SCI)

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Spinal cord stimulation (SCS) has been shown in previous studies to be capable of restoring motor and autonomic function in patients with chronic complete spinal cord injury (SCI). Clinical studies ha...

Detailed Description

Spinal cord injury (SCI) causes damage to motor, sensory, and autonomic function below the level of injury. This can have a huge impact on the daily function of the patients, with devastating effects ...

Eligibility Criteria

Inclusion

  • American Society of Anesthesiologist (ASA) status I-III
  • Age 18-70 years old
  • Patients with SCI more than 2 years
  • Traumatic or atraumatic spinal cord injury
  • American Spinal Injury Association (ASIA) Impairment Scale A and B
  • Have previous MRI to document extent of spinal cord injury before recruitment

Exclusion

  • Chronic opioid user
  • Presence of chronic pain condition (pain duration over 3 months)
  • Alcohol or substance abuse
  • active and unaddressed psychiatric diseases

Key Trial Info

Start Date :

September 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2029

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT07139496

Start Date

September 1 2025

End Date

March 1 2029

Last Update

December 1 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Queen Mary Hospital

Hong Kong, Hong Kong